Evidence shows that IL-22 can directly modulate lipid metabolism by promoting lipolysis and enhancing fatty acid β-oxidation in adipose tissue and hepatocytes of obese mice, thus attenuating obesity-associated fatty liver and steatosis [27,52]. The gene discussed is IL22; the disease is fatty liver disease.